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Article:  
We read with much interest the article “Analysis of heart injury laboratory parameters in 
273 COVID-19 patients in one hospital in Wuhan, China” by Han et al as published in 
March 2020. In this retrospective, single center study authors have discussed the role of 












acute cardiovascular injury marker including CK-MB, Myoglobulin, cardiac troponin I 
(cTnI) and NT- proBNP on the outcome of 273 patients with COVID-19 disease. Authors 
have suggested that elevated concentrations of these enzymes in venous blood were 
related to disease severity and poor outcome1. We believe that this topic is relevant and 
evolving. We have the following additional comments for further understanding of the 
disease and its various pathophysiological bases in cardiac involvement.  
Non ischemic and ischemic myocardial injury has been attributed to be the two principle 
pathophysiological basis of acute cardiac injury in COVID-19 patients2. Of the two, 
nonischemic myocardial injury is predominant and is secondary to multiple secondary 
mechanisms. The various distinct mechanisms for non-ischemic myocardial injuries that 
have been published in the literature are – [i] cytokine storm as documented by 
significantly raised inflammatory markers [ii] secondary to hemophagocytic 
lymphohistiocytosis, [iii] viral myocarditis with reports of progression to fulminant 
myocarditis, [iv] stress cardiomyopathy, and [v] hypoxia induced cardiac myocyte 
apoptosis3-5.  
Markers of cardiac injury including CK-MB, MYO, LDH, ultra-TnI, NT-proBNP, D-
dimer are elevated in any of the above patterns of cardiac injury. However, in most 
studies of COVID-19 patients showing increased mortality, an elevated troponin I level 
has been uniformly associated with uncontrolled inflammation secondary to cytokine 
storm. This phenomenon of infection related increased cytokine release is identified by 
an elevated plasma level of several inflammatory markers. Various inflammatory markers 
that are shown to be elevated in patients with COVID-19 related cardiac injury are C- 
reactive protein (CRP), procalcitonin, ferritin, D- dimer, Interleukin - 2 (IL-2), 












Interleukin – 7 (IL-7), granulocyte – colony stimulating factor, IgG- induced protein 10, 
chemokine ligand 3 and tumor necrosis alpha2,3,6. Did the authors have the details of 
various inflammatory markers among their patients? 
Not only that cytokine storm related cardiac injury has been consistently reported in most 
studies, but it has also been identified to be predictors of complications like acute 
respiratory distress, acute kidney injury, the severity of illness, requirement of intensive 
care unit admission and higher mortality2,7,8.  
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